These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 16951476)
21. Risedronate for Paget's disease of bone. Med Lett Drugs Ther; 1998 Aug; 40(1034):87-8. PubMed ID: 9731243 [No Abstract] [Full Text] [Related]
22. [Risedronate, a new diphosphonate in osteoporosis and Paget's disease]. Bannwarth B Presse Med; 2002 Mar; 31(8):340-2. PubMed ID: 11913075 [No Abstract] [Full Text] [Related]
23. Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000. Drake WM; Kendler DL; Brown JP Clin Ther; 2001 Apr; 23(4):620-6. PubMed ID: 11354395 [TBL] [Abstract][Full Text] [Related]
24. Management of Paget's disease of bone. Langston AL; Ralston SH Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244 [TBL] [Abstract][Full Text] [Related]
25. Chondrosarcoma in Paget's disease of bone. Ibáñez R; Gutierrez R; Fito C; del Val N; Loza E Clin Exp Rheumatol; 2005; 23(2):275. PubMed ID: 15895907 [No Abstract] [Full Text] [Related]
26. [Therapy of Paget's disease]. Kurth AA Orthopade; 2007 Feb; 36(2):118, 120-3. PubMed ID: 17252256 [TBL] [Abstract][Full Text] [Related]
27. Etidronate disodium in the treatment of Paget's disease of bone. Krane SM Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538 [TBL] [Abstract][Full Text] [Related]
28. Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. Hosking D; Lyles K; Brown JP; Fraser WD; Miller P; Curiel MD; Devogelaer JP; Hooper M; Su G; Zelenakas K; Pak J; Fashola T; Saidi Y; Eriksen EF; Reid IR J Bone Miner Res; 2007 Jan; 22(1):142-8. PubMed ID: 17032148 [TBL] [Abstract][Full Text] [Related]
29. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates. Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558 [TBL] [Abstract][Full Text] [Related]
31. Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone. Devogelaer JP; Malghem J; Stasse P; Nagant de Deuxchaisnes C Bone; 1997 Mar; 20(3):259-61. PubMed ID: 9071477 [TBL] [Abstract][Full Text] [Related]
32. [Risedronate for treatment of osteoporosis]. Hagino H Nihon Rinsho; 2009 May; 67(5):948-53. PubMed ID: 19432115 [TBL] [Abstract][Full Text] [Related]
33. Paget's disease and bisphosphonates. Liel Y N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16354901 [No Abstract] [Full Text] [Related]
34. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834 [TBL] [Abstract][Full Text] [Related]
35. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment. Polyzos SA; Anastasilakis AD; Makras P; Terpos E Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962 [TBL] [Abstract][Full Text] [Related]
36. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone]. Nuti R; Turchetti V; Righi G; Vattimo A Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555 [TBL] [Abstract][Full Text] [Related]
37. [Paget's disease: case report]. Wegierska M; Ignaczak P; Zalewska J; Jeka S Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549 [TBL] [Abstract][Full Text] [Related]
38. Current treatment approaches for Paget's Disease of Bone. Brandi ML Discov Med; 2010 Sep; 10(52):209-12. PubMed ID: 20875342 [TBL] [Abstract][Full Text] [Related]